Goo adquisicion isavuconazol en frasco y capsulas
About This Opportunity
Chile contract award (transport & logistics): Goo adquisicion. By Chile Mercadopublico. Awarded to LABORATORIO BIOTOSCANA FARMA SPA (CLP 209.3M, Feb 2026).
This is a supplies contract in the transport and logistics, health and medical services and trade and industry sectors, with a focus on Pharmaceuticals, Warehousing and Manufacturing. Located in Chile, Latin America, this opportunity is open to firms and consortiums.
Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the transport and logistics sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
This tender, issued by a contracting authority in Chile, seeks the procurement of Isavuconazole in both vial and capsule formulations. The procurement is for essential pharmaceutical supplies, aiming to secure a reliable source of this antifungal medication. Bidders are invited to submit proposals for the supply of Isavuconazole, which is typically used for the treatment of invasive fungal infections.
The scope of this tender encompasses the provision of Isavuconazole in two distinct forms: sterile vials for intravenous administration, likely requiring specific packaging and storage conditions to maintain product integrity, and oral capsules for patient convenience. Interested parties should be prepared to demonstrate their capacity to supply high-quality pharmaceutical products that meet stringent regulatory standards applicable in Chile.
Typical requirements for such a tender would include adherence to Good Manufacturing Practices (GMP), provision of comprehensive product specifications, certificates of analysis, and evidence of regulatory approval from relevant health authorities. Furthermore, bidders may be required to detail their proposed delivery schedules, logistical capabilities, and after-sales support. The contracting authority will likely evaluate submissions based on a combination of technical merit, product quality, pricing, and the supplier's experience and reliability in providing pharmaceutical goods.
This procurement is critical for ensuring the availability of effective antifungal treatments within the Chilean healthcare system.
Data provenance
This notice is sourced from Chile Mercado Publico and was originally published on March 7, 2026. Last refreshed 1 day ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
Frequently asked questions about this tender
How much was the contract awarded for?
LABORATORIO BIOTOSCANA FARMA SPA was awarded the contract for CLP 209,307,000. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Chile. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Chile Mercado Publico to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to LABORATORIO BIOTOSCANA FARMA SPA. The award notice is archived on BidsFactory for transparency and market intelligence.
What type of contract is this?
This is a Supplies contract in the Transport & Logistics sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.